Status: current, Defined. Date: 30-Nov 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2976691000168114 | Daratumumab (Janssen) (daratumumab 400 mg / 20 mL) injection, 1 x 20 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2976701000168114 | Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | Is a | daratumumab 400 mg/20 mL injection, 20 mL vial | true | Inferred relationship | Some | ||
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | has TPUU | Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | true | Inferred relationship | Some | 1 | |
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | has TP | Daratumumab (Janssen) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | Is a | True | Daratumumab (Janssen) 400 mg/20 mL injection, 20 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR